Figure 2. Combined individual PK serum concentrations (µg.mL-1) of INM 004 vs time (h) of study subjects. Panel A Stage I, Cohort I (2.00 mg.kg-1 single dose regime). Panel B Stage I, Cohort II (4.00 mg.kg-1 single dose). Panel C, Stage II (4.00 mg.kg-1 repeated dose regime).